Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

FITBI vs GBFH: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

FITBI Wins Head-to-Head Institutional Verdict (4–0 across 6 Pillars · 8–1 Matrix Metrics)

FITBI Overall Winner 6-Pillar Tally: FITBI 4 – 0 GBFH (2 Tie) Matrix Metrics: FITBI 8 – 1 GBFH

As of Nov 19, 2026, Fifth Third Bancorp Depositary Shares (FITBI) is the stronger overall head-to-head candidate over GBank Financial Holdings Inc. (GBFH) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FITBI carries a Unified Composite Score of 66.0/100 (BUY) at $25.69 (N/M Forward P/E, 38.5% operating margin), whereas GBFH carries 40.0/100 (SELL) at $14.39 (23.4x Forward P/E, 38.5% operating margin).

  • Technical & Structure Timing Caution: FITBI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 62.3); meanwhile GBFH is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About FITBI vs GBFH
FITBI NASDAQ Head-to-Head Winner
Fifth Third Bancorp Depositary Shares
State Commercial Banks
$25.69
+0.12% 1D
Market Cap $17.7B
TTM Revenue $8.13B
Forward P/E N/M
Beta / 30D Vol 0.09β · 3% Vol
Unified Composite Score
66.0 / 100 BUY
Tech 75.0 Fund 62.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 62
RSI-14: 62.3 · SMA20: $25.61 · SMA50: $25.45
GBFH NASDAQ
GBank Financial Holdings Inc. Common Stock
State Commercial Banks
$14.39
-3.36% 1D
Market Cap $217.0M
TTM Revenue $75M
Forward P/E 23.4x
Beta / 30D Vol 0.13β · 46% Vol
Unified Composite Score
40.0 / 100 SELL
Tech 25.0 Fund 61.0 Flow 50.0 Mom 69.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.2%), weak momentum, RSI 25
RSI-14: 25.1 · SMA20: $15.63 · SMA50: $17.20

6-Pillar Scorecard Institutional Category Breakdown (FITBI 4 – 0 GBFH)

Columns: Metric · FITBI · GBFH
1. Valuation Multiples FITBI
Forward P/E N/M 23.4x
Trailing P/E 7.4x 12.0x
PEG Ratio N/M N/M
EV / Revenue 2.2x 2.9x
2. Growth & Scale FITBI
Revenue Growth (YoY) -1.0% -1.5%
Earnings Growth (YoY) -1.2% -11.5%
TTM Revenue (USD) $8.13B $75M
Market Cap $17.7B $217.0M
3. Profitability & Quality FITBI
Gross Margin 100.0% 100.0%
Operating Margin 38.5% 38.5%
Net Profit Margin 28.4% 24.0%
Return on Equity (ROE) 12.5% 10.8%
4. Balance Sheet & Cash Flow FITBI
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $25.13 Book/Sh · 12.5% ROE $12.08 Book/Sh · 10.8% ROE
Dividend Yield 5.45% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew Thin ADR Chain N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity 61.5% of Rev ($5.00B) 61.5% of Rev ($46M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role Banks - Regional Operator Banks - Regional Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: FITBI (8) vs GBFH (1)
Institutional Metric FITBI GBFH Criterion Row Edge
Market Capitalization
Scale
$17.7B $217.0M Larger Scale FITBI
Trailing P/E Ratio
Valuation
7.4x 12.0x Lower Multiple FITBI
Forward P/E Ratio
Valuation
N/M 23.4x Lower Multiple GBFH
Revenue Growth (YoY)
Growth
-1.0% -1.5% Higher Growth FITBI
Operating Margin (TTM)
Profitability
38.5% 38.5% Higher Margin Tie
Net Profit Margin
Profitability
28.4% 24.0% Higher Margin FITBI
Return on Equity (ROE)
Capital Efficiency
12.5% 10.8% Higher ROE FITBI
52-Week Range Position
Momentum
68% ($25–$26) 11% ($12–$38) Stronger Trend FITBI
Beta / 30D Volatility
Risk Regime
0.09β · 3% Vol 0.13β · 46% Vol Lower Realized Risk FITBI
Unified Institutional Score
Composite Signal
66.0 / 100 (BUY) 40.0 / 100 (SELL) Higher Composite FITBI
Trailing 12M Revenue (USD)
Operating Scale
$8.13B $75M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.2x EV/Rev N/M PEG · 2.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($25.13 Book/Sh · 12.5% ROE) N/A ($12.08 Book/Sh · 10.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GBFH +14.31 pp
FITBI: +0.9% · GBFH: +15.21%
3M Horizon GBFH +17.57 pp
FITBI: +0.2% · GBFH: +17.77%
6M Horizon FITBI +10.17 pp
FITBI: -0.27% · GBFH: -10.44%
1Y Horizon FITBI +5.21 pp
FITBI: +0.43% · GBFH: -4.78%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FITBI vs GBFH. Trailing 12-month operating profitability (FITBI 38.5% vs GBFH 38.5%) and valuation multiples (FITBI N/M vs GBFH 23.4x Forward P/E) are benchmarked directly in Pillar 4 below.

FITBI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$8.13B
Gross Margin100.0%
Op. Margin38.5%
ROE / Fwd P/E12.5% · N/M
GBFH ADR TTM Benchmark FX-Normalized USD
TTM Revenue$75M
Gross Margin100.0%
Op. Margin38.5%
ROE / Fwd P/E10.8% · 23.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
FITBI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FITBI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GBFH UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GBFH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
FITBI Moat Profile High-Margin Pricing Power Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $17.7B market capitalization and 38.5% operating margin.
OpEx & R&D Reinvestment 61.5% of Rev ($5.00B)
90D Engineering Disclosures 0 Published
GBFH Moat Profile High-Margin Pricing Power Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $217.0M market capitalization and 38.5% operating margin.
OpEx & R&D Reinvestment 61.5% of Rev ($46M)
90D Engineering Disclosures 0 Published

Investor FAQ FITBI vs GBFH Key Questions & Quantitative Answers

As of Nov 19, 2026, Fifth Third Bancorp Depositary Shares (FITBI) is the stronger overall head-to-head candidate over GBank Financial Holdings Inc. (GBFH) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FITBI carries a Unified Composite Score of 66.0/100 (BUY) at $25.69 (N/M Forward P/E, 38.5% operating margin), whereas GBFH carries 40.0/100 (SELL) at $14.39 (23.4x Forward P/E, 38.5% operating margin). Technical & Structure Timing Caution: FITBI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 62.3); meanwhile GBFH is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

FITBI leads the Growth & Scale pillar: FITBI posts -1.0% YoY revenue growth and -1.2% YoY earnings growth on $8.13B TTM revenue (100.0% gross margin, 38.5% operating margin), compared with GBFH at -1.5% YoY revenue growth and -11.5% YoY earnings growth on $75M TTM revenue (100.0% gross margin, 38.5% operating margin). On trailing 12-month operating scale, FITBI generates $8.13B in USD-normalized revenue versus $75M for GBFH. In operating R&D and SG&A reinvestment, FITBI deploys 61.5% of Rev ($5.00B) (0 90-day corporate R&D disclosures) versus 61.5% of Rev ($46M) (0 disclosures) for GBFH.

FITBI screens cheaper on headline valuation multiples. FITBI trades at N/M Forward P/E, 7.4x Trailing P/E, N/M PEG, and 2.2x EV/Revenue (unreported cash flow margin), whereas GBFH trades at 23.4x Forward P/E, 12.0x Trailing P/E, N/M PEG, and 2.9x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FITBI (12.5% ROE) versus GBFH (10.8% ROE) capital efficiency.

In options market volatility and institutional positioning, FITBI carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.09β · 3% Vol realized risk). By comparison, GBFH carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.13β · 46% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.